[Clinical evaluation of sulbactam/cefoperazone in the field of obstetrics and gynecology]. 1984

Y Yabuki, and A Asamoto, and T Hoshiba

One or 2 grams of sulbactam/cefoperazone (SBT/CPZ) in 250 ml of 5% glucose solution was administered twice daily by drip infusion to 10 patients with female genital organ infections. The clinical effectiveness was seen in 8 patients but not in 2 patients associated with emergence of replaced organism or non-eradicated causative organism. Antibacterial activity of SBT/CPZ vs. CPZ in the 20 clinical isolates revealed that SBT/CPZ was 1 or 3 tubes superior to CPZ alone in the beta-lactamase producing organisms, but, 1 or 2 tubes inferior to CPZ in the beta-lactamase non-producing organisms. In 1 case increases in GOT and GPT, and in another increases in GOT and GPT, and a decrease in platelets were observed even though their degrees were mild.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010397 Penicillanic Acid A building block of penicillin, devoid of significant antibacterial activity. (From Merck Index, 11th ed) Acid, Penicillanic
D002438 Cefoperazone Semisynthetic broad-spectrum cephalosporin with a tetrazolyl moiety that is resistant to beta-lactamase. It may be used to treat Pseudomonas infections. Cefobid,Cefoperazon,Cefoperazone Sodium,Cefoperazone Sodium Salt,Céfobis,T-1551,T1551,Salt, Cefoperazone Sodium,Sodium Salt, Cefoperazone,Sodium, Cefoperazone,T 1551
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D005831 Genital Diseases, Female Pathological processes involving the female reproductive tract (GENITALIA, FEMALE). Gynecologic Diseases,Female Genital Diseases,Diseases, Female Genital,Diseases, Gynecologic,Female Genital Disease,Genital Disease, Female,Gynecologic Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Y Yabuki, and A Asamoto, and T Hoshiba
October 1984, The Japanese journal of antibiotics,
Y Yabuki, and A Asamoto, and T Hoshiba
October 1984, The Japanese journal of antibiotics,
Y Yabuki, and A Asamoto, and T Hoshiba
October 1984, The Japanese journal of antibiotics,
Y Yabuki, and A Asamoto, and T Hoshiba
November 1984, The Japanese journal of antibiotics,
Y Yabuki, and A Asamoto, and T Hoshiba
November 1984, The Japanese journal of antibiotics,
Y Yabuki, and A Asamoto, and T Hoshiba
December 1984, The Japanese journal of antibiotics,
Y Yabuki, and A Asamoto, and T Hoshiba
November 1984, The Japanese journal of antibiotics,
Y Yabuki, and A Asamoto, and T Hoshiba
November 1984, The Japanese journal of antibiotics,
Y Yabuki, and A Asamoto, and T Hoshiba
November 1984, The Japanese journal of antibiotics,
Y Yabuki, and A Asamoto, and T Hoshiba
October 1984, The Japanese journal of antibiotics,
Copied contents to your clipboard!